Key terms
About TELA
TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TELA news
Apr 15
9:30am ET
Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)
Apr 15
7:09am ET
Tela Bio announces U.S. commercial launch of OviTex IHR
Apr 08
7:05am ET
Tela Bio appoints Howard Langstein as VP, medical affairs, surgeon strategy
Mar 22
7:23am ET
Tela Bio price target lowered to $12 from $15 at Piper Sandler
Mar 22
7:18am ET
Piper Sandler Initiates a Buy Rating on TELA Bio (TELA)
Mar 22
12:30am ET
Analysts Offer Insights on Healthcare Companies: TELA Bio (TELA) and Vor Biopharma (VOR)
Mar 21
4:33pm ET
TELA Bio Announces Investor Update and Hernia Mesh Launch
Mar 21
4:08pm ET
TELA Bio reports Q4 EPS (53c), consensus (43c)
Mar 21
7:35am ET
Strategic Divestiture and Innovative Product Launch Fuel Buy Rating for TELA Bio
Mar 21
7:13am ET
TELA Bio announces U.S. commercial launch of LIQUIFIX
Mar 20
9:00am ET
Analysts’ Top Healthcare Picks: Jasper Therapeutics (JSPR), Alphatec Holdings (ATEC)
Mar 20
7:08am ET
TELA Bio anounces sale of distribution rights for wound care product
Mar 20
7:06am ET
MiMedx enters agreement with TELA Bio for fibrillar collagen wound dressing
No recent press releases are available for TELA
TELA Financials
Key terms
Ad Feedback
TELA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TELA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
